Results 101 to 110 of about 176,181,179 (281)

Analysis on status of fear of disease progression in patients with nasopharyngeal carcinoma after 5 years discharged from hospital and its influencing factors

Huli yanjiu, 2020
ObjectiveThis paper investigated status quo on fear of disease progression in nasopharyngeal carcinoma patients after 5 years discharged from hospital,and analyzed its influencing factors.MethodsA total of 100 nasopharyngeal carcinoma patients(NPC ...
QIU Liyan, YANG Li
doaj  

Effects of the “Internet +” nursing model based on user profiling on postoperative recovery in breast cancer: A prospective randomized controlled clinical trial

International Journal of Nursing Sciences
Objectives: This study aimed to explore the effectiveness and advantages of an “Internet +” nursing model based on user profiling in the rehabilitation of postoperative breast cancer patients. Methods: Breast cancer patients admitted to the hospital from
Xiuyuan Xie, Yuanfang Ren, Jia Yao, Yujie Fei, Fenghe Liu, Qian Tong, Juanjuan Huang, Meihong Kou, Cuifeng Jin, Weijuan Yang, Haiping Xu   +10 more
doaj   +1 more source

Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl‐2 and Mcl‐1 blockade in preclinical glioblastoma models

FEBS Open Bio, EarlyView.
The PAM pathway and its impact on cellular metabolism. Color‐coded key symbols represent Rapamycin (R, orange, targeting mTOR) and Dactolisib (D, green, targeting PI3K/mTOR), indicating their sites of action. Created with BioRenders.com. Glioblastoma resists therapy through interconnected survival programs.
Kai Zhao, Leonie Meyer, Madita Braun, Katharina Otte, Celine Bitter, Maite Pawlik, Hartmann Raifer, Frederik Helmprobst, Axel Pagenstecher, Hans Urban, Michael C. Burger, Michael W. Ronellenfitsch, Joachim P. Steinbach, Jarmila Jedelská, Shamim Bagheri, Behrooz H. Yousefi, Pietro Di Fazio, Markus Luster, Andreas H. Mahnken, Andreas Neubauer, Andreas Burchert, Christopher Nimsky, Jörg W. Bartsch, Tillmann Rusch   +23 more
wiley   +1 more source

Psychological burden and resilience factors in patients with Alveolar Echinococcosis - A cross-sectional study.

PLoS Neglected Tropical Diseases, 2019
BackgroundAlveolar echinococcosis (AE) is a parasitic zoonosis resembling malignancy due to its clinically silent infiltrative growth, predominately in the liver.
Christoph Nikendei, Anja Greinacher, Anastasiya Berkunova, Thomas Junghanss, Marija Stojkovic   +4 more
doaj   +1 more source

Anxiety, Depression, Fear of Progression and Illness Adaptation in Breast Cancer Patients

BRAIN. Broad Research in Artificial Intelligence and Neuroscience
Introduction: Fear of progression, anxiety and depression are highly interconnected in breast cancer patients and survivors, and they shape adaptation to the disease. Materials and Methods: This observational, cross-sectional, multicentre, non-interventional study was conducted in two hospitals in Romania during one month (July 2026).
Gabriela Rahnea Nita, Alexandru Bogdan Ciubara, Mihai Teodor Georgescu, Laura Florentina Rebegea, Dan Ilie Damboiu, Anamaria Ciubara, Rares Nicolae Vadana, Laurentiu Tony Hangan, Andreea Georgia Cernea, Ionut Simion Coman, Roxana Andreea Rahnea-Nita   +10 more
openaire   +2 more sources

Five‐Year Outcomes of Laparoscopic Sphincter‐Preserving Surgery for Rectal Cancer: A Prospective Study in Elderly Vietnamese Patients

Aging and Cancer, EarlyView.
This prospective study demonstrates that laparoscopic sphincter‐preserving surgery is feasible for elderly patients. While overall survival reaches 70% at 5 years, advanced T‐stage and the omission of neoadjuvant therapy significantly drive recurrence, highlighting the need for personalized geriatric protocols despite logistical challenges.
Huu Duc Ho, Quang Le, Ngoc Thach Tran, Van Viet Ung, Loc Vu   +4 more
wiley   +1 more source

[Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]

, 2006
OBJECTIVES: Fear of progression is one of the most prevalent symptoms in cancer patients. The aim of this study was to validate the 12-item short version of the Fear of Progression Questionnaire (FoP-Q-SF). METHODS: A total of 1083 breast cancer patients
Mehnert, A;Herschbach, P;Berg, P;Henrich, G;Koch, U
core  

Fear of cancer recurrence and its predictive factors among Iranian cancer patients [PDF]

, 2014
Fear of cancer recurrence (FOCR) is one of the most important psychological problems among cancer patients. In extensive review of related literature there were no articles on FOCR among Iranian cancer patients.
Nejad, Zahra K., Ferguson, Caleb (R19103), Ferguson, C, Aghdam, Alireza M., Asghar Mohammadpoorasl, Nejad, Z, AlirezaMohajjel Aghdam, Aghdam, A, Zohreh Sanaat, Rahmani, Azad, Sanaat, Z, Mohammadpoorasl, Asghar, ZahraKochaki Nejad, Sanaat, Zohreh, Azad Rahmani, Mohammadpoorasl, A, Caleb Ferguson, Rahmani, A   +17 more
core   +1 more source

Understanding and Mitigating the Risk of Accelerated Biological Aging in Survivors of Cancer: A Scoping Review

Aging and Cancer, EarlyView.
Cancer treatment is associated with measurable acceleration of biological aging across epigenetic, telomere, senescence, and immune biomarkers. However, biomarker validation and interventional strategies remain limited, especially in hematologic malignancies, underscoring the need for standardized multi‐omic aging assessments and adequately powered ...
Moataz Ellithi, Emily Herdman, Danielle Westmark, Vijaya R. Bhatt   +3 more
wiley   +1 more source

The Sum of all fears : conceptual challenges with measuring fear of cancer recurrence [commentary]

, 2016
Fear of cancer recurrence (FCR) is increasingly recognised as a major concern for people with cancer once active treatment is completed. Several instruments have been designed to assess FCR; however, no gold standard has emerged.
Costa, Daniel S. J, Smith, Allan "Ben", Fardell, Joanna E   +2 more
core   +1 more source